Sign Up to like & get
recommendations!
1
Published in 2018 at "International Immunopharmacology"
DOI: 10.1016/j.intimp.2018.07.037
Abstract: &NA; Agonists of nucleotide oligomerization domain (NOD) 1 and NOD2 receptors represent a promising class of immunostimulants and immunological adjuvants. Here, we describe a cell‐based test system to assess their pharmacokinetics. In this system, NOD1…
read more here.
Keywords:
pharmacokinetics nod1;
system;
cell based;
nod1 nod2 ... See more keywords